GlobalData on MSN
FDA accepts Beren Therapeutics’ NDA for Niemann-Pick disease
The submission includes data indicating a meaningful survival benefit for infantile-onset NPC patients treated with adrabetadex.
CELEBRATION, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with ...
CELEBRATION, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA), a rare disease therapeutics company, proudly supports the Niemann-Pick community on Global Niemann-Pick ...
In Pick’s disease, as in Alzheimer’s disease and frontotemporal dementia, tangled tau spells trouble. In this subtype of FTD, abnormal clumps of three-repeat tau called Pick bodies abound in neurons.
DETAIL ALL THOSE THINGS IN YOUR SEVEN-DAY FORECAST. ERIC. THANK YOU. WELL, TO HELP THEIR DAUGHTER, ONE FAMILY IS MAKING IT THEIR MISSION TO FIND A CURE FOR NIEMANN-PICK DISEASE. IT’S A DEVASTATING ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results